Jacob Berlin
16Patents
2h-index
30Co-inventors
50Inventor score
Filing activity: Dec 18, 2006 → Jul 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10426801B2 | Encapsulated diagnostics and therapeutics in nanoparticles—conjugated to tropic cells and methods for their use | Human Necessities | 3 | Active |
| US8916606B2 | Therapeutic compositions and methods for targeted delivery of active agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US9572834B2 | Use of carbon nanomaterials with antioxidant properties to treat oxidative stress | Performing Operations; Transporting | 2 | Active |
| US8008224B2 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | Performing Operations; Transporting | 1 | Active |
| US11015266B2 | Chemically encoded spatially addressed library screening platforms | Performing Operations; Transporting | 1 | Active |
| US11554178B2 | Compositions and methods of modulating macrophage activity | Chemistry; Metallurgy | 0 | Active |
| US11549941B2 | Nucleic acid-functionalized nanoparticles | Physics | 0 | Active |
| US10760181B2 | Chemically encoded spatially addressed library screening platforms | Performing Operations; Transporting | 0 | Active |
| US9776242B2 | Multiphoton induced direct aggregate scribing | Emerging Cross-Sectional Technologies | 0 | Active |
| US10767278B2 | Chemically encoded spatially addressed library screening platforms | Performing Operations; Transporting | 0 | Active |
| US8361922B2 | Organometallic ruthenium complexes and related methods for the preparation of tetra-substituted and other hindered olefins | Performing Operations; Transporting | 0 | Active |
| US11696959B2 | Nanoparticle-cell construct with platinum anti-cancer agent | Performing Operations; Transporting | 0 | Active |
| US11015265B2 | Chemically encoded spatially addressed library screening platforms | Performing Operations; Transporting | 0 | Active |
| US11156960B2 | Focusing light inside scattering media with magnetic particle guided wavefront shaping | Physics | 0 | Active |
| US11191745B2 | Silica nanoparticle with an insoluble drug | Emerging Cross-Sectional Technologies | 0 | Active |
| US9795691B2 | Chemically-linked nanoparticles | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.